General CEU: Using the Autism Impact Measure (AIM)

Dr. Stephen Kanne, PhD is a Professor of Psychology in Clinical Psychiatry at Weill Cornell Medical College and the Director of the Center for Autism and the Developing Brain at Weill Cornell Medical School. Prior to this, he was the Executive Director of the MU Thompson Center for Autism and Neurodevelopmental Disorders and a Professor in the Department of Health Psychology. He received his bachelor’s degree and his doctoral degree in clinical psychology from Washington University. He completed a clinical internship at the University of California, San Diego, followed by a post-doctoral fellowship in Pediatric Neuropsychology at the University of Missouri-Columbia. He then worked for 5 years at St. Louis Children’s Hospital as a pediatric neuropsychologist followed by 4 years in the at the University of Missouri specializing in autism and pediatric neuropsychology, before becoming the Director of the Autism Center at the Baylor College of Medicine and Texas Children's Hospital. He returned to the University of Missouri in 2012 as the Executive Director of the Thompson Center, and transitioned to Weill Cornell in 2020. Dr. Kanne’s current research interests focus on children with autism, targeting diagnostic tools, outcome measures, behavioral phenotyping, co-occurring symptoms, evidence-based therapies, and subthreshold symptoms. In addition to publishing in the areas of autism, Dr. Kanne has also published in the areas of cognitive neuropsychology, history of neuropsychology, and pediatric traumatic brain injury. Dr. Kanne is board certified in Clinical Neuropsychology. He also loves to teach and train, providing workshops nationally and internationally in autism.